DDDRX
Price
$16.10
Change
-$0.04 (-0.25%)
Updated
Oct 7 closing price
Net Assets
845.73M
RLBCX
Price
$38.68
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

DDDRX vs RLBCX

Header iconDDDRX vs RLBCX Comparison
Open Charts DDDRX vs RLBCXBanner chart's image
Macquarie Wealth Builder R
Price$16.10
Change-$0.04 (-0.25%)
VolumeN/A
Net Assets845.73M
American Funds American Balanced R3
Price$38.68
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
DDDRX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
DDDRX vs. RLBCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDRX is a Buy and RLBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. DDDRX (846M). RLBCX pays higher dividends than DDDRX: RLBCX (1.49) vs DDDRX (1.27). DDDRX was incepted earlier than RLBCX: DDDRX (22 years) vs RLBCX (23 years). DDDRX (1.34) is less costly to investors than RLBCX (0.89). DDDRX is a more actively managed with annual turnover of: 66.00 vs. RLBCX (44.00). DDDRX has a lower initial minimum investment than RLBCX: DDDRX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 9.62 vs. DDDRX (5.40). RLBCX return over 5 years is better than : 40.56 vs. DDDRX (31.01).
DDDRXRLBCXDDDRX / RLBCX
Total Expense Ratio1.310.89147%
Annual Report Gross Expense Ratio1.340.89151%
Fund Existence22 years23 years-
Gain YTD10.71714.15876%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets846M266B0%
Annual Yield % from dividends1.271.4985%
Returns for 1 year5.409.6256%
Returns for 3 years28.1849.8257%
Returns for 5 years31.0140.5676%
Returns for 10 years40.9573.2956%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTR5.10N/A
+0.08%
Mesa Royalty Trust
SUPN48.07-0.24
-0.50%
Supernus Pharmaceuticals
COHR113.56-1.21
-1.05%
Coherent Corp
ABOS1.88-0.06
-3.09%
Acumen Pharmaceuticals
CINT4.58-0.40
-8.03%
CI&T